41
Participants
Start Date
August 4, 2020
Primary Completion Date
February 22, 2024
Study Completion Date
February 22, 2024
danicamtiv
Myosin activator
Local Institution - 0012, A Coruña
Local Institution - 0001, Philadelphia
Local Institution - 0010, Washington D.C.
Local Institution - 0013, Majadahonda
Local Institution - 0004, Charleston
Local Institution - 0011, El Palmar
Local Institution - 0009, Tampa
Local Institution - 0008, Germantown
Local Institution - 0019, Columbus
Local Institution - 0005, Rochester
Local Institution - 0014, Heidelberg
Local Institution - 0018, Austin
Local Institution - 0007, La Jolla
Local Institution - 0015, Würzburg
Local Institution - 0002, Chicago
Local Institution - 0003, Boston
Local Institution - 0006, Cleveland
Local Institution - 0016, London
Local Institution - 0017, Middlesex
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY